These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1426824)

  • 1. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
    J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
    Møller S; Hansen EF; Becker U; Brinch K; Henriksen JH; Bendtsen F
    Liver; 2000 Feb; 20(1):51-9. PubMed ID: 10726961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
    Merkel C; Gatta A; Bolognesi M; Finucci G; Battaglia G; Angeli P; Zuin R
    Dig Dis Sci; 1988 Sep; 33(9):1103-9. PubMed ID: 3409797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
    Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
    J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
    Vachiery F; Moreau R; Gadano A; Yang S; Sogni P; Hadengue A; Cailmail S; Soupison T; Lebrec D
    Dig Dis Sci; 1996 Sep; 41(9):1722-6. PubMed ID: 8794785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
    Garcia-Tsao G; Groszmann RJ
    Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of terlipressin on blood volume distribution in patients with cirrhosis.
    Kiszka-Kanowitz M; Henriksen JH; Hansen EF; Møller S; Bendtsen F
    Scand J Gastroenterol; 2004 May; 39(5):486-92. PubMed ID: 15180188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
    Moreau R; Cailmail S; Valla D; Lebrec D
    Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
    Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
    J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
    Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison.
    Ding C; Wu X; Fan X; He C; Li J
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1242-6. PubMed ID: 23489113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
    Rector WG; Hossack KF
    J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
    Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
    J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study.
    Kalambokis GN; Pappas K; Tsianos EV
    Angiology; 2012 Apr; 63(3):199-205. PubMed ID: 21733953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.